Anna Bandurska-Luque Selected Research

trypsin carboxypeptidase peptide inhibitor

12/2017

Modeling tumor control probability for spatially inhomogeneous risk of failure based on clinical outcome data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Bandurska-Luque Research Topics

Disease

10	Squamous Cell Carcinoma of Head and Neck 05/2019 - 01/2015
8	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 01/2015
5	Hypoxia (Hypoxemia) 05/2019 - 01/2017
3	Neoplasms (Cancer) 01/2019 - 01/2015
2	Xerostomia 01/2021 - 01/2015
2	Deglutition Disorders (Dysphagia) 01/2021 - 01/2015
2	Lymphatic Metastasis 02/2019 - 01/2019
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 03/2019
1	Residual Neoplasm 01/2017
1	Mucositis 01/2015
1	Trismus (Lockjaw) 01/2015
1	Vasculitis (Vasculitides) 01/2012
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2012

Drug/Important Bio-Agent (IBA)

4	Protons (Proton)IBA 01/2021 - 01/2015
4	fluoromisonidazoleIBA 02/2019 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 05/2019 - 01/2017
1	thiamine triphosphorate (TTP)IBA 01/2019
1	trypsin carboxypeptidase peptide inhibitorIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 01/2012

Therapy/Procedure

8	Chemoradiotherapy 05/2019 - 01/2015
5	Radiotherapy 01/2021 - 08/2015
5	Proton Therapy 01/2021 - 01/2015
5	Therapeutics 11/2017 - 01/2015
2	Immunotherapy 01/2019 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2019